Earnings summaries and quarterly performance for Integer Holdings.
Executive leadership at Integer Holdings.
Payman Khales
President and Chief Executive Officer
Diron Smith
Executive Vice President and Chief Financial Officer
Jim Stephens
President, Cardiac Rhythm Management & Neuromodulation
John Harris
Executive Vice President, Global Operations and Manufacturing Strategy
Lindsay Blackwood
Senior Vice President, General Counsel and Corporate Secretary
Board of directors at Integer Holdings.
Cheryl Capps
Director
Craig Maxwell
Director
Donald Spence
Director
Filippo Passerini
Director
James Hinrichs
Director
Jean Hobby
Director
Michael Coyle
Director
Pamela Bailey
Chair of the Board
Sheila Antrum
Director
Tyrone Jeffers
Director
Research analysts who have asked questions during Integer Holdings earnings calls.
Richard Newitter
Truist Securities
8 questions for ITGR
Suraj Kalia
Oppenheimer & Co. Inc.
8 questions for ITGR
Nathan Treybeck
Wells Fargo Securities
7 questions for ITGR
Andrew Cooper
Raymond James
6 questions for ITGR
Brett Fishbin
KeyBanc Capital Markets
6 questions for ITGR
Joanne Wuensch
Citigroup Inc.
6 questions for ITGR
Craig Bijou
Bank of America Securities
4 questions for ITGR
Matthew O'Brien
Piper Sandler
4 questions for ITGR
Travis Steed
Bank of America
4 questions for ITGR
Matthew O'Brien
Piper Sandler & Co.
3 questions for ITGR
Brett Fishman
KeyBanc Capital Markets Inc.
2 questions for ITGR
Joanne Lynch
Citigroup Inc.
1 question for ITGR
Kristen Stewart
CL King & Associates
1 question for ITGR
Matt O'Brien
Piper Sandler Companies
1 question for ITGR
Recent press releases and 8-K filings for ITGR.
- Law Offices of Howard G. Smith announced an investigation into potential breaches of fiduciary duties by the board of directors of Integer Holdings Corporation (ITGR) on behalf of investors.
- This investigation follows Integer's announcement on October 23, 2025, that it had reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion.
- The company also informed investors of anticipated net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026.
- Management revealed that sales of three new products, including two electrophysiology devices, were expected to decline in 2026 due to slower market adoption than forecasted.
- Following this news, Integer's stock price fell $35.22 per share, or 32.3%, to close at $73.89 per share on October 23, 2025.
- The Law Offices of Frank R. Cruz is investigating potential claims against Integer Holdings Corporation's (ITGR) board of directors for alleged breaches of fiduciary duties to shareholders.
- This investigation follows Integer's announcement on October 23, 2025, that it reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion and anticipated lower net sales and organic sales growth for 2026.
- Management attributed the revised guidance to expected declines in sales of three new products, including two electrophysiology devices, due to slower market adoption, with the impact on Cardio & Vascular sales growth continuing into 2026.
- Following this news, Integer's stock price fell $35.22 per share, or 32.3%, to close at $73.89 per share on October 23, 2025.
- Integer Holdings reported strong Q4 2025 financial results, with sales of $472 million (up 5% on a reported basis) and Adjusted EPS of $1.76 (up 23%). For the full year 2025, sales reached $1.854 billion (up 8% on a reported basis) and Adjusted EPS was $6.40 (up 21%).
- For 2026, the company expects reported sales between $1,826 million and $1,876 million (down 1% to up 1%) and Adjusted EPS between $6.29 and $6.78 (down 2% to up 6%). This outlook includes a 3-4% headwind from lower-than-anticipated market adoption of three new products.
- Integer repurchased $50 million of common stock in Q4 2025 and announced an intention to initiate an additional $50 million accelerated share repurchase program.
- Management expressed confidence in the underlying business, which is expected to grow 4-6% in 2026 excluding the new product headwinds, and anticipates returning to 200 basis points above-market organic sales growth in 2027.
- Integer Holdings (ITGR) reported full-year 2025 sales of $1.854 billion, an 8% increase on a reported basis, and Adjusted EPS of $6.40, up 21%. For Q4 2025, sales were $472 million (up 5% reported) and Adjusted EPS was $1.76 (up 23%).
- The company issued its 2026 financial outlook, projecting reported sales between $1,826 million and $1,876 million (down 1% to up 1%) and Adjusted EPS between $6.29 and $6.78 (down 2% to up 6%).
- This 2026 outlook includes a 3%-4% headwind from three new products with lower-than-expected market adoption; however, the underlying business is expected to grow 4%-6%.
- Integer repurchased $50 million of common stock in Q4 2025 and announced plans for an additional $50 million accelerated share repurchase program.
- Management remains confident in returning to 200 basis points above-market organic growth in 2027, driven by a strong product development pipeline.
- Integer Holdings reported strong Q4 2025 sales of $472 million (up 5% reported, 2% organic) and adjusted EPS of $1.76 (up 23%), contributing to full year 2025 sales of $1.854 billion (up 8% reported, 6% organic) and adjusted EPS of $6.40 (up 21%).
- The company announced a $50 million accelerated share repurchase program for 2026, following $50 million in share repurchases during Q4 2025.
- For full year 2026, Integer Holdings projects reported sales between $1,826 million and $1,876 million (down 1% to up 1%) and adjusted EPS between $6.29 and $6.78 (down 2% to up 6%).
- The 2026 outlook is impacted by a 3%-4% headwind from lower market adoption of three new products, though the underlying business is expected to grow 4%-6%.
- Management expressed confidence in returning to 200 basis points above-market organic growth in 2027.
- Integer Holdings reported Q4 2025 sales of $472 million, a 5% increase, and Adjusted EPS of $1.76, up 23%. Full-year 2025 sales grew 8% to $1,854 million, with Adjusted EPS rising 21% to $6.40.
- For 2026, the company projects sales between $1,826 million and $1,876 million (a change of -1% to 1%) and Adjusted EPS in the range of $6.29 to $6.78 (a change of -2% to 6%).
- While reported organic sales growth for 2026 is anticipated to be flat to up 3%, the company expects 4% to 6% organic growth when excluding select new product headwinds.
- Integer repurchased $50 million in shares during Q4 2025 and plans to initiate an approximate $50 million Accelerated Share Repurchase (ASR) program.
- Integer Holdings Corporation reported strong financial results for the fourth quarter of 2025, with sales increasing 5% to $472 million and Adjusted EPS growing 23% to $1.76 per share compared to Q4 2024.
- For the full year 2025, the company achieved an 8% increase in sales to $1.854 billion and a 21% rise in Adjusted EPS to $6.40 per share. Adjusted EBITDA also increased 12% to $402 million.
- The 2026 outlook projects sales between $1,826 million and $1,876 million and Adjusted EPS in the range of $6.29 to $6.78.
- In Q4 2025, the company repurchased $50 million of common shares and plans to commence an additional accelerated share repurchase program of approximately $50 million. Total debt as of December 31, 2025, was $1.185 billion, resulting in a leverage ratio of 3.0 times adjusted EBITDA.
- Integer Holdings Corporation reported full-year 2025 sales of $1.854 billion, an 8% increase, and adjusted EPS of $6.40 per share, a 21% increase compared to 2024.
- For 2026, the company projects sales between $1,826 million and $1,876 million and adjusted diluted EPS between $6.29 and $6.78.
- The company intends to commence an accelerated share repurchase program (ASR) to repurchase approximately $50 million of its common stock.
- Integer continues to expect 200 basis points above-market organic sales growth in 2027.
- Kahn Swick & Foti, LLC reminds investors that the deadline to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation is February 9, 2026.
- The lawsuit alleges that Integer and certain executives failed to disclose material information during the Class Period from July 25, 2024, to October 22, 2025.
- This action follows Integer's October 23, 2025, disclosure of lower full-year 2025 sales guidance and reduced 2026 sales growth expectations, which caused the company's shares to fall by more than 32%.
- Integer Holdings Corporation (ITGR) is facing a securities fraud class action lawsuit alleging the company misrepresented demand, sales growth, and its competitive position in the electrophysiology (EP) market.
- The lawsuit stems from Integer's October 23, 2025, disclosure, where it lowered its 2025 sales guidance to a range of $1.840 billion to $1.854 billion (previously $1.850 billion to $1.876 billion) and warned of weak 2026 growth.
- This disclosure caused Integer's stock to drop $35.22 per share, a one-day decline exceeding 32%.
- Investors who purchased Integer common stock between July 25, 2024, and October 22, 2025, have until February 9, 2026, to seek appointment as lead plaintiff.
Quarterly earnings call transcripts for Integer Holdings.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more